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Recently, in vivo confocal microscopy is used to examine the human corneal nerve fibers morphology. Corneal nerve fiber
architecture and its role are studied in healthy and pathological conditions. Corneal nerves of rats were studied by nonspecific
acetylcholinesterase (NsAchE) staining. NsAchE-positive subepithelial (stromal) nerve fiber has been found to be insensitive to
capsaicin. Besides, NsAchE-negative but capsaicin-sensitive subbasal nerve (leash) fibers formed thickmesh-like structure showing
close interconnections and exhibit both isolectinB4- and transient receptor potential vanilloid channel 1- (TRPV1-) positive. TRPV1,
TRPV3, TRPA (ankyrin) 1, and TRPM (melastatin) 8 are expressed in corneal nerve fibers. Besides the corneal nerve fibers, the
expressions of TRPV (1, 3, and 4), TRPC (canonical) 4, and TRPM8 are demonstrated in the corneal epithelial cell membrane.
The realization of the importance of TRP channels acting as polymodal sensors of environmental stresses has identified potential
drug targets for corneal disease. The pathophysiological conditions of corneal diseases are associated with disruption of normal
tissue innervation, especially capsaicin-sensitive small sensory nerve fibers.The relationships between subbasal corneal nerve fiber
morphology and neurotrophic keratopathy in corneal diseases are well studied. The recommended treatment for neurotrophic
keratopathy is administration of preservative free eye drops.
1. Introduction
The structure and distribution pattern of corneal nerves
have been extensively studied by histochemical and in vivo
confocal microscopic (IVCM) methods to date. Recently,
the human corneal nerve fiber structure is comprehensively
demonstrated on the anterior-cornea of whole mount prepa-
ration (WMP) from 16 donors aged 19–78 years using 𝛽-
tubulin as a primary antibody [1]. Main thick stromal nerve
bundles enter the cornea at the corneoscleral limbus and
make midstromal plexus and dense subepithelial plexus
(SEP), by repeatedly branching. Straight and curvilinear
nerve fibers of the SEP penetrate Bowman’s membrane and
innervate corneal epithelium [1]. This distribution pattern
of the corneal nerves seems to be a common feature as
described below. However, a correlation between neuropep-
tides, isolectin B4 (IB4: a plant lectin specifically binds
to small sensory neurons), or transient receptor potential
(TRP) channels and a classic neurotransmitter acetylcholine
is poorly understood. One of the aims of this review is trying
to focus on this issue. Further, differences in the structures of
corneal nerves between animals and human are referred to in
the recent reports.
It is well known that the cornea is densely innervated.
For example, the density of nerve fibers in the rabbit corneal
epithelium was estimated as 300–600 times and 20–40
times compared to that of skin and tooth pulp, respectively
[2]. Corneal nerves respond to many sensations such as
pain, temperature, or touch and functions in corneal reflex
(blink) and tear production [3]. Moreover, corneal nerves
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contain many neurotrophic factors such as substance P (SP),
calcitonin gene-related peptide (CGRP), epidermal growth
factor (EGF), nerve growth factor (NGF), brain-derived
neurotrophic factor (BDNF), and neurotrophin- (NT-) 3 [3].
These substances are directly released from unmyelinated C-
fibers according to the inflammatory conditions and have
functions to sustain the normal cornea and corneal wound
healing (neurotrophic function) [3]. Majority of innervation
to cornea is considered to be nociceptive in nature [4].
Approximately 7000 nociceptors/mm2 are estimated to be
present in the human corneal epithelium [5].
Corneal nerve dysfunction due to mechanical or chem-
ical trauma, inflammation, refractive surgery, and infections
frequently induces corneal diseases such as opacities suffering
from impaired vision. Therefore, precise understanding of
the corneal nerves in health and disease has a high clinical
impact for the patients with various corneal abnormalities.
On this subject, an understanding of the corneal nerve fiber
structures of animals is momentous for human therapeutic
criteria (regeneration of corneal nerves and epithelial cells).
Moreover, the cellular andmolecular changes within primary
sensory neurons underlying nociception, wound healing,
scarring, dry eye, and immune status of the cornea are raised
with regard to the TRP channels.
2. Structure and Distribution of
Corneal Nerves
Corneal nerves have been visualized by some histochemical
staining methods with gold chloride (AuCl), cholinesterase
enzymes, and immune-reaction of antigen (neuropeptides)
to their antibodies. Although numerous neurotransmitters
and neuropeptides are found in the cornea and tear fluid
[5], cholinesterase-positive (+) nerve fibers innervating the
cornea are preferentially described in this section. Subse-
quently, human corneal subbasal nerve plexus demonstrated
by IVCM is dealt with in the latest reports.
2.1. Specific Acetylcholinesterase- (AchE-) and Nonspecific Ace-
tylcholinesterase- (NsAchE-) Positive Corneal Nerves. Since
cholinesterase enzymes are present in sensitive end organs of
the skin, the detection of corneal nerves with these enzymes
is not surprising [6]. A histochemical demonstration by
specific acetylcholinesterasemethod (AchE) (acetylcholine as
substrate with inhibitors) or nonspecific acetylcholinesterase
method (NsAchE) (butyrylthiocholine as substrate and
BW284C51 as inhibitor of AchE-activity or acetylcholine as
substrate without inhibitor) has been well used to visualize
nerve fibers innervating the cornea in detail in many studies
using several mammalian species: rabbit [6, 7], rat [8–13],
and dog [11], including human [14]. The extracted corneas
are examined in these studies on WMP [6, 7, 10–14] or flat
(WMP in a broad sense [8, 9]) sectioned preparations for light
microscopy [7, 8] and electron microscopy [7, 8]. A WMP is
convenient for demonstration of the entire morphology and
distribution pattern of corneal nerves.
2.1.1. Cholinesterase-Positive Nerve Fibers in Animal Cornea.
Both AchE (+) and NsAchE (+) nerve fibers were present
in either stroma or epithelium [6–8]. AchE (+) nerve fibers
in the subepithelial stroma are divided into fibrillary fibers
(subepithelial nerve plexus) and perpendicularly penetrate
into the epithelium at Bowman’s membrane [6–8]. After
penetration, subepithelial stromal nerve fibers with Schwann
cells branch naked subbasal leash fibers [7, 8]. These leash
fibers are running between epithelial cells (intraepithelial
nerve) with beadings and finally form free nerve endings
[7, 8].
NsAchE (+) nerve fibers appeared as the large nerve
fiber bundles which make plexus anastomosing with each
other in the stroma [12]. The NsAchE (+) stromal nerve
fibers and their branches were quantitatively analyzed [9]. No
significant differences in the stromal nerve fiber density were
seen between each quadrant of the same cornea [9]. Stromal
nerves are more closely innervated in the periphery than the
central area of corneas [9, 12]. The density of stromal nerves
(subepithelial nerve plexus) in the WMP was quantitatively
estimated using computer morphometry and double staining
methods (NsAchE and AuCl) [10]. The density of subep-
ithelial nerves increased by 48% than only NsAchE or AuCl
staining in the same cornea [10]. Visualization of epithelial
nerves and their fine leash fibers were also enhanced by
double staining. Age-related characteristics of NsAchE (+)
corneal nerves (stromal nerve plexus) were studied in dogs
[11]. NsAchE (+), thick 12–15 nerve bundles distributed evenly
around limbus fromwhich 2 nerve bundles of equal thickness
branch run to the central area ramifying into thin nerve
bundles. NsAchE (+) nerve fibers are also innervated in
epithelial layer. Length of NsAchE (+) nerve fibers of adult
dogs (1–7 years) was longer than those of young (until 1 year)
and old dogs (more than 8 years) [11].
The nerve fiber density (mm/mm2) of NsAchE (+) stro-
mal subepithelial plexus of rats with development (from 7
to 77 days after birth) was studied using WMP [12]. The
density showed a decrease during development, indicating
that the growth of NsAchE (+) nerve is not parallel with the
enlargement of the cornea [12].
2.1.2. Cholinesterase-Positive Nerve Fibers in Human Cornea.
Entire normal architecture and distribution of human corneal
nerves were studied with WMP by NsAchE method [14].
Over 44 thick stromal nerve trunks enter the cornea in a
similar manner from the limbus and run towards the central
portion [14]. Anterior stromal nerves peculiarly ramify at
the mid-peripheral zone of the cornea. Passing through
Bowman’s membrane, they terminate as thick bulb from
whichmany subbasal nerve (leash) fibers rise.The leash fibers
vertically enter into the epithelium at the mid-peripheral
cornea and run towards the corneal apex with a whorl-like
or vortex structure [14]. The whirl-like pattern of subbasal
nerves was also reported by immunostaining method using
antibody for neuron specific 𝛽-tubulin in the mouse whole
mount cornea [15, 16]. As a whole, the NsAchE (+) nerve
fibers’ architecture and distribution pattern in the human
cornea are very similar to those of mammals, especially in
mice [16].
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The electron microscopic study revealed that the bundles
of leash fibers consist of single or over 10 unmyelinated axons
[17]. Leash fibers interconnect making subbasal plexus which
is rich and complex in the central area than peripherally.
From these leash fibers fine terminal fibers perpendicularly
branch off and run between epithelial cells up to the ocular
surface (intraepithelial nerve fibers). There are many free
nerve endings (terminal boutons) en route to the surface.
2.2. Effects of Capsaicin on Corneal NsAchE-Positive and
CGRP-ir Nerve Fibers. Some studies [18–20] reported that
corneal nerve fibers stained with AuCl remarkably decreased
following neonatal treatment with a sensory neurotoxin,
capsaicin. The effects of neonatal pretreatment of capsaicin
on the NsAchE (+) subepithelial stromal nerve fibers were
investigated in adult rats [12, 13]. To our surprise, NsAchE
(+) nerve fiber densities showed no significant differences
compared with those of controls in any developmental ages
[12]; these nerve fiberswere insensitive to capsaicin.However,
protein gene product 9.5 (PGP9.5: a marker protein of
peripheral nerve fibers), immunoreactive (ir) intraepithelial
nerve fibers or terminals decreased, causing a reduction of
eye wiping by fourth-sixth to that of control by instillation
of 100 𝜇M capsaicin onto the cornea [12]. According to the
long survival times (4, 8, and 12 mos.) after subcutaneous
(s.c.) neonatal capsaicin injection (50mg/kg), various types
of corneal lesions (neuroparalytic keratitis) occurred [13].
Occurrence of ulcers and irregular excess sprouting of fine
NsAchE (+) nerve fibers were prominent in the animals
12 mos. after treatment. Even the short survival periods
(5–75 days) after high dose of capsaicin application (total:
150mg/kg), the pretreated animals showed corneal lesions
and neovascularization, but not nerve fiber sprouting [13].
Thus, the longer survival times and the higher doses of
capsaicin are key factors for inducing corneal lesion and
neovascularization.
Neonatal intraperitoneal (i.p.) application of capsaicin
induced the complete [20] (total dose: 150mg/kg), or approx-
imately 67% loss [21] (50mg/kg, i.p.) of the CGRP-ir nerve
fibers so that they seemed to have important roles in corneal
sensory, blink, and trophic functions. Chronic keratitis and
neovascularization severely occurred between 4 and 6 weeks
after treatment with capsaicin [21].
2.3. Relations between Acetylcholine-Positive and Other
Neurotransmitters-Positive Nerve Fibers in the Cornea. A
similar pattern and density in the rat corneal stromal CGRP-
ir nerves to those stained with NsAchE or AuCl suggested
that majority of corneal stromal NsAchE (+) nerves are
also CGRP-ir [22]. Similarly, AchE (+) thick nerve fiber
bundles in the guinea pig corneal stroma coexisted with
small CGRP-ir nerve fibers [23]; that is, thick nerve bundles
are composed of AchE (+) and CGRP-ir nerve fibers. On
the other hand, coexistence of neuropeptide galanin with SP
[24] or SP with CGRP was demonstrated in the same corneal
nerve fibers of mice [16] and pigs [24]. Therefore, capsaicin
can deplete SP and CGRP from the corneal nerve fibers in
the animals treated neonatally [4].
Another sensory neuropeptides neurokinin A (NKA, one
of the tachykinin) and secretoneurin (generated by prote-
olysis of chromogranins) are present in the rat and human
corneas [25, 26]. After neonatal capsaicin treatment, NKA-
and secretoneurin-ir small neurons decreased by 50–60% in
the rat TG [25, 26]. In addition to the classic neurotransmit-
ters SP and CGRP, both NKA and secretoneurin may play a
role in the corneal function.
Dense innervation of CGRP-ir and capsaicin recep-
tor, transient receptor potential vanilloid 1- (TRPV1-) ir,
subepithelial stromal nerve fibers was demonstrated in the
rat cornea, though their colocalization with acetylcholine
was not examined [27]. In addition, NsAchE-negative (−)
but capsaicin-sensitive nerve fiber bundles making dense
meshwork structures were seen in the rat cornea [28]. These
meshwork structures are very similar to the leash fibers
forming subbasal nerve plexus, showing a whirl-like pattern
at the center of the cornea [28]. They were composed of both
IB4-positive and TRPV1-ir fine nerve fibers [28]. Probably,
SP (+), CGRP (+), TRPV1 (+), and IB4 (+) nerve fibers make
meshwork bundles as subbasal leash fibers, but NsAchE (+)
stromal nerve fibers never join in it. Thus, the presence of
NsAchE (+) stromal nerve fibers and NsAchE (−) subbasal
probable peptidergic leash fibers showing IB4 (+) or TRPV1
(+) indicate that these two groups are distinct populations
from each other at least in the rat. The former is capsaicin-
insensitive (resistant) and the latter capsaicin-sensitive.
Although there are many peptidergic, AchE (+), or non-
peptidergic IB4 (+) nerve fibers in small neurons in the DRG
and TG of mammals, it should be noted that a considerable
number of capsaicin-resistant small sensory neurons always
remained within them after neonatal capsaicin treatment
[25, 26, 29, 30].
The presumptive explanation on the morphology and
distribution of corneal nerves and their changes after cap-
saicin treatment are illustrated in Figure 1 mainly based
on the results of our studies [12, 13, 27, 28]. The report of
Marfurt et al. [1] is also referred to because the distribu-
tion pattern of subbasal leash fibers is very similar to the
meshwork bundles of subbasal leash seen in the rat cornea.
Apparently, these subbasal leash nerve fibers sensitive to
capsaicin have a crucial role for protection and repair the
corneal tissue from chemical, mechanical, and infectious
injuries. Numerous studies revealed that the loss of capsaicin-
sensitive nerve fibers by capsaicin treatment induces corneal
lesions in rodents [13, 18–21, 31–33]. Therefore, preservation
and regeneration of capsaicin-sensitive nerve fibers in the
cornea are a fundamental prescription for the maintenance
of healthy corneal tissue.
2.4. Corneal Nerves by In Vivo Confocal Microscopy (IVCM).
From the beginning of 20th century, morphology of human
corneal nerves has been progressively studied using IVCM
[34–48]. A noninjurious way to examine the living human
cornea is of special benefit in the use of IVCM [44]. However,
an examination of the morphology of living corneal nerves
is confined to the area of central cornea and subbasal nerve
fibers [14]. Their innervation pattern and structure are very
similar to the images in the previous reports described above.
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Figure 1: A putative architecture and distribution pattern of corneal nerve fibers of rats in normal (a) and their alterations after neonatal
capsaicin treatment (b). Thick stromal subepithelial nerve fiber plexus are reactive to NsAchE. The NsAchE-positive (+) nerve plexus
(indicated in blue) are resistant to capsaicin. On the other hand, NsAchE-negative (−) nerve fiber bundles showing dense interconnections
(meshwork structure) reactive to neuropeptides and IB4 or TRPV1 seem to be subbasal leash fibers in rats cornea (indicated in orange).
They are assumed to be destroyed (especially in the central portion) after neonatal capsaicin treatment (b), but NsAchE (+) nerves are never
influenced by capsaicin. Probably, capsaicin-sensitive neurotrophic peptidergic nerve fibers are destroyed by neonatal capsaicin treatment
resulting in the defect of epithelial cells (neuroparalytic keratitis) and desensitization to chemical or thermal stimuli. BEP: basal epithelial
plexus of leash fibers, BL: Bowman’s layer, DEC: defect of epithelial cells, and SEP: subepithelial (stromal) plexus.
An appearance of whirl-like pattern in the central cornea of
the subbasal nerve plexus is conspicuous [35, 40, 42] as well
as demonstrationwithNsAchE [14] and immunostaining [15]
methods. The IVCM has been used to clinically evaluate the
morphological changes (i.e., tortuosity [45] loss or decrease
[46, 47], and small fiber abnormalities [48]) of subbasal
corneal nerves in various types of neuropathy.
3. Roles of TRP Channels in the Cornea
3.1. Overview of TRP Channels. There are two types of
Ca2+ channels (i.e., voltage-dependent and receptor-operated
channels). The transient receptor potential (TRP) chan-
nels are of the latter type. TRP channels can be classified
into six main subfamilies: the TRPC (canonical), TRPV
(vanilloid), TRPM (melastatin), TRPP (polycystin), TRPML
(mucolipin), and TRPA (ankyrin) groups. TRP channels are
expressed in almost every tissue and cell type and display an
important role in the regulation of various cell functions [49].
The TRPC subfamily has seven members (TRPC1–7)
[49–51]. It is activated by stimulation of G-protein-coupled
receptors and receptor tyrosine kinase [49]. TPRC3, TRPC6,
and TRPC7 are highly expressed in smooth and cardiac
muscle cells [49]. The TRPV subfamily consists of TRPV1–6;
TRPV1–4 have thermal sensitivity, and TRPV5 and TRPV6
uptake Ca2+ in the kidney and intestine [49]. The TRPM
subfamily consists of TRPM1–8. Melastatin-1 is initially iden-
tified inmelanoma cells so that theTRPM-1 is termed because
of its homologywithmelastatin-1. TRPMchannels are related
to cell growth, differentiation, and programmed cell death
[52]. TRPM2–4 and 8 have thermal sensitivity (threshold
temperature 8–28∘C) [53, 54].The TRPP subfamily is isolated
as causal factors of polycystic kidney disease. TRPP1 and
TRPP2, which are associated with the interaction between
cells and cell matrix, were found to coassemble at the plasma
membrane and produce a new channel. The TRPML seems
to participate in secretion of the stomach parietal cells,
corneal epithelial cells, pancreatic acinar cells, hepatocytes,
chondrocytes, and renal duct cells [55]. Mucolipidosis type
IV (MLIV) is an autosomal recessive developmental disorder
caused by mutations in the MLIV gene (MCOLN1), which
encodes TRPML1 (mucolipin-1), a member of the TRPML
subfamily [56].The TRPA1 channel, also known as ANKTM1
or p120 protein [57], was found in a subset of sensory
neurons coexpressing with TRPV1. TRPA1 channel can sense
nociceptive cold at approximately 15∘C [58]. Inflammatory
agents mustard oil (allyl isothiocyanate: AITC, a constituent
of horseradish and wasabi) and tetrahydrocannabinol (THC)
excite over 20% of cultured rat TG neurons via ANKTM1,
representing a subset (30–50%) of capsaicin-sensitive TRPA1-
expressing small neurons having receptors for mustard oil
and THC [59]. Bandell et al. [60] showed that both cin-
namaldehyde (the main constituent of cinnamon oil used as
flavor foods) and mustard oil activate only TRPA1.
The study on TRP channels in the ophthalmology area
started from 2000, when TRPML1 was identified as a causal
protein of mucolipidosis IV [55]. Since 2005, the relationship
between retinal photosensory nerve cells and TRPC channel
has attracted attention [61]. Moreover, Bellone et al. [62]
reported that TRPM1 is correlated with congenital night
blindness. Currently, the importance of TRP channels has
been recognized in cornea, conjunctiva [63], ciliary body
[64], and lens [65].
BioMed Research International 5
3.2. TRP Channels in Nociception of Cornea. For the first
time, one of the ion channels TRPV1 is identified in small pri-
mary sensory neurons and later in nonneuronal cell types [24,
66–68]. It is cloned as the receptor for capsaicin (CAP) and
activated by binding of various exogenous and endogenous
compounds [50, 69–71]. When the channels of a subset of
small sensory neurons are activated by CAP, they are opened
and followed by inflow of the small molecule such as 5(6)-
carboxyfluorescein- (FAM-) conjugated N-ethyl-lidocaine
(QX-314) through the pore [72]. Structurally resembling
vanilloids, such as resiniferatoxin (RTX) and olvanil, are also
potent activators of this channel.
Ophthalmic branches of the trigeminal nerve are rich
in distribution on the cornea (Figure 1) and conducive to
touch or pain transmission from the tissue. Impairment of
corneal sensitivity results in diminished blink and lacrimal
reflexes. Our previous studies on corneal nerves suggested
that the mesh-like fibers that were not stained with NsAchE
are CAP-sensitive and make bunches of fine IB4- or TRPV1-
positive nerve fibers, indicating that they are nociceptive
in nature [24]. In agreement with this finding, numerous
substances (e.g., components of shampoo and soap) causing
eyes pain in daily life induce an influx of Ca2+ throughTRPV1
in vitro [73, 74]. The number of eye-wipes in response to
stimulation by CAP was significantly reduced in the RTX-
treated group in rats [75]. Desensitization lasted a few days
without affecting the healing process of the injured corneal
epithelium as well as the blink reflex of the cornea [75].
Therefore, RTX is thought to be safe and useful drug in pain
control after ophthalmic operation and eye disorders [75].
The results verified that TRPV1 plays an essential role in the
corneal pain generation.
TRPV3 is transcribed from a gene adjacent to TRPV1,
therefore, considered to form heteromeric channels with
TRPV1. Naturally, TRPV1/3 heterotetrameric channels have
different response properties from those of individual
homotetrameric channels. Like TRPV1, TRPV3 expressed
in keratinocytes and peripheral sensory neurons displays
a marked sensitization (lowered threshold) to heat upon
repeated stimulation [76]. Because significant delayed tail
flick response (>50∘C) and withdrawal latencies of hind paw
at 55∘C were seen in TRPV3-knockout (KO) mice, TRPV1
and TRPV3 are suggested to share a common noxious heat
response [77].
TRPA1 channel is known to exist in the corneal nerve
endings [24, 78–82]. There have been many reports on the
TRPA1 concerning the pain; a pain in the trachea due to
inflammation by smoking [83], inflammatorymediators such
as prostaglandins (PG), and the intracellular alkalization
[84, 85]. In addition to the pain, TRPA1 is associated with
respiratory depression [86]. When the mice inhaled the
materials, aerosolized hypochlorous acid or hydrogen per-
oxide (TRPA1 agonist), a respiratory frequency was remark-
ably decreased. The respiratory depressions were not seen
in the TRPA1-deficient mice [86]. TRPA1 is activated by
various factors, that is, an intracellular increase of Ca2+
concentrations, pH [84], cold [59], and mechanical force
[87]. TRPA1 is also activated by chemicals such as allyl
isothiocyanate (AITC; a component of wasabi) [59, 86],
cinnamaldehyde (a component of cinnamon) [88], allicin
(an ingredient of the garlic) [89], and formaldehyde [90].
Cinnamaldehyde causes burning and tingling sensations in
humans following oral administration. Then Bandell et al.
[60] suggested that the noxious and burning sensation by
cold is transmitted through TRPA1 channel. Interestingly,
TRPA1 has a sensitivity to isothiocyanates. Sensitivity to these
electrophiles derives most likely from a reversible covalent
bond [91]. The methyl isothiocyanate (MITC), sometimes
called methyl mustard contained in a natural world, fends
from animal predator [92]. MITC is used for agriculture to
control nematodes, fungi, weeds, and insects. When MITC
enters the atmosphere, it affects the human. Tear flow occurs
after exposing the eye to MITC (tear gas effect) [92]. Thus,
TRPA1 channel may be a sensor to protect the cornea from
damage.
3.3. TRP Channels in Regeneration of Corneal Epithelial Cell.
Renewal of the corneal epithelium is essential for corneal
transparency and normal vision [93]. This layer has a barrier
function against noxious stimuli [94]. The barrier properties
are sustained by rigid joint structure between adjacent epithe-
lial cells.The function of the corneal epithelium ismaintained
by replacing superficial terminally differentiated cell with
proliferating basal cells undergoing migration into the upper
layers of this tissue.
A growth factor (GF) is a naturally occurring sub-
stance capable of stimulating cell growth, proliferation and
differentiation, and tissue healing. The GF includes the
following types: epidermal growth factor (EGF), platelet-
derived growth factor (PDGF), transforming growth factor
(TGF), insulin-like growth factor (IGF), fibroblast growth
factor (FGF), and nerve growth factor (NGF). The epithe-
lial basal cell growth is controlled by EGF. An injury of
the corneal epithelium stimulates the repair of the wound
healing by EGF and other various different growth factors
[95]. The EGF stimulates many signal pathways (namely,
extracellular signal-regulated kinase: ERK, protein kinase
A: PKA, protein kinase C: PKC, phosphoinositide 3-kinase:
PI3-kinase, phospholipase C/, phospholipase D, and inositol
1,4,5-trisphosphate: IP3) [96–98]. The role of these cascades
is to increase intracellular calcium via the stimulation of
capacitative calcium entry (CCE) [99]. The CCE means
calcium influx due to activation by depletion in calcium
stores.Therefore, it is also called store-operated calcium entry
(SOCE).
Expression of TRPC4 is demonstrated in the corneal
epithelial cell membrane by both immunocytochemistry and
electron microscope studies [100]. TRPC4 is involved in the
increment of cell proliferation by EGF [100]. EGF activates
PLC-IP
3
cascade. PLC-IP
3
decrease the intracellular Ca2+
stores [79].The decrease of Ca2+ stores works as feedback and
provokes the increase of Ca2+ inflow into the cytoplasm by
opening the store-operated Ca2+ channels (TRPC4) [99].The
increase of intracellular Ca2+ activates the downstream of the
mitogen-activated protein kinase (MAPK) signal cascade and
is followed by stimulation of PKA, PKC, Janus kinase/signal
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transducers and activators of transcription (JAK/STAT),
and the phosphatidylinositol-3-kinase/protein kinase B (PI3-
K/Akt).The activation of suchMAPK signals can increase the
cell proliferation and migration [98].
TRPV3 is broadly expressed in neuronal (DRG cells and
central nervous system) and nonneural tissues including
epidermis, keratinocyte, intestinal epithelial cells, and vas-
cular endothelial cells [101]. The channel of TRPV3 is gated
by warm temperatures at 32–39∘C [74, 102, 103]. It is also
activated by compress (heating pad) and ointment of the
natural ingredients of camphor and the herbs (Origanum
vulgare, Syzygium aromaticum, and Thymus vulgaris [104]).
Aijima et al. [105] found that deficiency of TRPV3 decreased
the reproduction of the epithelial cells compared with that
of wild type. Recently, the functional expression of TRPV3
was demonstrated in human corneal epithelial cells (HCEC)
[106]. Analysis of wound healing showed that the calcium
ion inflow through TRPV3 in HCEC induces an increase
of the epithelial cells proliferation [107]. TRPV3 seems to
have an essential role in controlling the proliferation and the
differentiation of epithelial cells via calcium entry.
Cannabinoids receptor subtype 1 (CB1) regulates many
essential physiological processes including the control of neu-
rotransmitter release, pain and analgesia, energy homeostasis
modulation, and the immune cells function associated with
guanosine triphosphate (GTP) binding protein [108, 109].
TRPV1 and CB1 are coexpressed and interact functionally
in neuronal mesencephalic cultures [110], colon epithelium
[111], myometrial smooth muscle cells [112], and primary
sensory neurons [113]. The activity of TRPV1 in primary
sensory neurons can be lowered by activation of CB1, though
inhibitory effect of CB1 can be reduced in inflammatory
conditions [113]. Yang et al. [114] showed the coexistence of
TRPV1 and CB1 in HCEC. Injury of the corneal epithelium
induces the release of endogenous activating substances, that
is, anandamide and bradykinin, which are agonists of CB1
and TRPV1 activators, respectively [114]. When TRPV1 and
CB1 are activated, proinflammatory cytokines (IL6 or IL8)
are released fromHCEC in the inflammatory condition. As a
result, the activated TRPV1 andCB1mediate cell proliferation
and increase of migration through EGF receptor transactiva-
tion and MAPK/Akt-linked signaling pathway [115].
3.4. TRP Channels in Inflammation of Cornea. Nociceptive
stimuli activate TRPV1 and induce proinflammatory cytokine
release [115]. Zhang et al. [116] confirmed functional TRPV1
expression in the HCEC. The HCEC stimulated by CAP
induced cationic electric current resulting in the increase
of intracellular Ca2+ concentrations [117]. The release of
proinflammatory cytokine (IL-6 and IL-8) is enhanced in
HCEC by CAP [115, 117]. Such effects on HCEC are thought
to be dependent on MAPK activation. Three inhibitors of
MAPK pathways (U0126, SB203580, and SP600125) restrain
the release of IL-6 and IL-8 [116]. Accordingly, TRPV1 chan-
nel contributes to the secretion of inflammatory mediators in
the corneal epithelium [116].
EGFR-independent TRPV1-linked signal pathway medi-
ates the release of IL-6 and IL-8 via TRPV1 stimulation [114].
On the contrary, the CB1 activation decreases the release
of IL-8 induced by TRPV1 stimulation [114]. CB1 receptor
is considered as an alternative medicine effective for the
decrease of TRPV1-induced inflammation in corneal injury
[114].
Expression of TRPV4 was demonstrated in peripheral
sensory neurons, hypothalamus, and keratinocytes [128].
Recently, TRPV4 expression is also detected in HCEC [124].
There is a cross-talk between osmotic and heat stimuli;
decline of osmotic pressure links to a decrease of temperature
threshold [128]. TRPV4 channel is necessary for cell volume
adjustment (regulatory volume decrease: RVD) after osmotic
expansion. It is activated by exposure of TRPV4 agonist (4
alpha-phorbol-didecanoate: 4𝛼-PDD) or hypotonicmedium.
An osmoregulation mechanism (RVD) is activated by an
increase in intracellular calcium level through TRPV4. As a
result, the volume of cells is kept constant [124]. Studies on
TRPV4 expression using HCEC would provide a drug target
therapy for preservation of corneal epithelial function during
exposure to a hypotonic challenge or a thermal stress.
3.5. TRP Channels in Fibrosis or Scarring of Cornea. The
healing process of corneal epithelium from alkali burn causes
severe and permanent visual impairment with tissue inflam-
mation, fibrosis, and scarring [118]. Loss of TRPV1 expression
or the blockage of TRPV1 inhibited severe or persistent
corneal inflammation and fibrosis/scarring [119]. Expression
of transforming growth factor type 1 (TGF1) and other
proinflammatory factors, that is, monocyte chemoattractant
protein-1 (MCP-1) and IL-6, decreased in the alkali burned
cornea of TRPV1-KO mice compared with those of the
wild type [120]. MCP-1 and IL-6 are known to aggravate
inflammation as chemoattractants of the inflammatory cells
[119]. Inactivation of TRPV1 has a possibility for the potential
medicine in improving the inflammatory/fibrogenic wound
healing [119].
3.6. TRP Channels in Dry Eye. TRPM8 channel can be
activated by cold temperature less than 25∘C and by exposure
to cooling compound such as menthol [53, 54]. The channels
are represented in the cool-sensitive primary sensory neurons
[120] and have specific electrophysiological properties [120,
129]. Madrid et al. [125] demonstrated TRPM8 channel
expression in corneal nerve terminals. TRPM8 channel
serves as “humidity detectors” sensing the slow temperature
decrease due to evaporation of surface tears on eyes [126].
TRPM8-KO mice do not show a response to noxious cold
stimulus but do show a reduction of basal tearing [125].
Moreover, the warming of cornea decreases the secretion of
tears [126]. These findings indicate a contribution of TRPM8
for basal tearing in cornea.
Hirata et al. found the two classes of corneal nerves
excited by drying the cornea: cold-sensitive (87%) and
cold-insensitive (13%) neurons [127]. The application of the
TRPM8 antagonist (N-(4-tertiarybutylphenyl)-4-(3-chloro-
pyridin-2-yl)-tetrahydropyrazine-1(2H)-carbox-amide) on
eyes induced a decrease of response to drying cornea
by 45–80% [127]. Curiously, the treatment could never
accomplish nonresponses. These results support an idea that
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Table 1: Role of TRP channels in the cornea.
TRPV1 TRPV3 TRPV4 TRPA1 TRPC4 TRPM8
Nociception I I
Regeneration I I I
Inflammation I I
Fibrosis or scarring I
Dry eye I I I
Tissue location Ner, Epi, End Ner, Epi, End Epi, End Ner Epi Ner, Epi, End
Reference number [24, 73–75, 109, 114–123] [106, 107] [124] [24, 78–82] [100] [125–127]
I: TRP channels participating in physiological and pathophysiological conditions; Ner: corneal nerve, Epi: corneal epithelial cell, and End: corneal endothelial
cell.
the channel other than TRPM8 contributes to tear secretion
as well. A candidate in place of TRPM8 channel for tear
secretion is probably TRPV4 channel as mentioned above.
TRPV1 or an interplay between TRPV1 and TRPM8 is
also relevant in dry eye diseases because TRPM8 activation
is suppressed through activation of TRPV1 in HCEC [121].
Thyronamine as well as icilin is a cooling agent that directly
activates TRPM8 at a room temperature. Moreover, thyron-
amine has an inverse effect on TRPM8 and TRPV1 activities
when CAP is applied onto the cornea. While thyronamine
activates TRPM8, TRPV1 stimulation by CAP is blocked,
thereby protecting the dry eye [122].
Notably, TRPV1 can be activated by hypertonicity similar
to patients with dry eyes. The activated TRPV1 induces
proinflammatory cytokine (IL-6) release viaMAPK signaling
pathway [123] and leads to inflammatory condition [121],
allowing of dry eye.
The role of each TRP channel is summarized in Table 1.
4. Pathogenesis and Treatment of
Neurotrophic Keratopathy
4.1.Morphology of Corneal Nerves by InVivo Corneal Confocal
Microscopy (IVCM). As described in the Introduction, the
morphology of the human corneal nerves has been demon-
strated in detail using in vivo corneal confocal microscopy
(IVCM) examination [5, 27, 41]. IVCM is not yet an essen-
tial examination technique to determine treatment strategy.
However, the relationship betweenmorphological changes of
corneal nerves elucidated by IVCM and corneal diseases is a
field of study that will be developed in the future. Recently,
IVCM is reported to be possible to detect the corneal nerve
degeneration which related to the severity of neurological
deficits in patients with mild multiple sclerosis [130]. The
possibility of IVCM as an imaging biomarker for multiple
sclerosis clinical course has also been reported [131]. In the
future, the treatment outcome after corneal transplantation
and/or the treatment result of ocular surface diseases such
as dry eye may dramatically improve with the new treatment
that takes into account innervation.
4.2. Neurotrophic Keratopathy. The corneal epithelial cells
have trophic dependence on sensory nerves innervating the
cornea (see Section 2.4). The extent of corneal lesions is
Figure 2: Stage 1 neurotrophic keratopathy (NK). Slit lamp micro-
scope image stained by fluorescein. Superficial punctate keratitis
(indicated by white arrows) occurred in a diabetic patient.
in association with the destruction of peptide containing
nerve fibers. Thus neuropeptidergic nerve fibers have neu-
rotrophic activities to the corneal epithelial cells [132]. In
other words, the corneal sensory nerves play an important
role in homeostasis (maintenance) of the corneal epithe-
lium. Neurotrophic keratopathy (NK) develops following the
breakdown of the homeostasis. A diagnosis of NK depends
on the past clinical history of the patient, because there
is no specific corneal finding. Mackie classified NK into 3
clinical stages [133, 134]. We show pictures of NK in each
stage after obtaining of informed consent from all patients for
publication of this review.
Thefirst stage is characterized by fluorescein or Rose Ben-
gal staining of the cornea. At this stage, superficial punctate
keratitis (Figure 2), corneal epithelial hyperplasia, stromal
scarring, and neovascularization are visible. The differential
diagnosis of this stage includes many common ocular surface
diseases, such as dry eye, contact lenswear, keratitis caused by
blepharitis, and drug-induced keratopathy. These common
diseases have certain symptoms, such as foreign body sen-
sation, burning sensation, pain, and epiphora; however NK
usually does not show any symptom.
The second stage shows a persistent epithelial defect
(PED) (Figures 3(a) and 3(b)), that is, oval or circular in
shape, and is often located in the superior half of the cornea.
The edge of the PED is generally surrounded by loose epithe-
lium that heals poorly and becomes rolled. Delayed PED
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Figure 3: Stage 2 persistent epithelial defect (PED). Slit lamp microscope image (a). PED is located in the center of the cornea with cloudy
stroma. Fluorescein staining image (b). The rolled edge of the PED can be seen.
Figure 4: PED due to brain surgery and diabetes followed by
infectious keratitis. The corneal epithelial disorder by NK led to
methicillin-resistant Staphylococcus aureus keratitis (this picture is
presented under the permission of Medical View Co., Ltd.).
healing causes a cloudy and oedematous cornea. However,
the inflammation in the anterior chamber rarely occurs.
The third stage shows a corneal ulcer with stromal
thinning. In this stage, secondary infectious keratitis (Fig-
ure 4) and corneal perforation may occur. The second and
the third stages can be confused with PED due to other
pathophysiological causes or infectious keratitis. The most
important key to distinguish stage 2 or 3 from PED caused by
another disorder or infections keratitis is the inflammatory
sign in the anterior chamber or a subjective complaint of
severe eye pain.
4.3. Corneal Nerve in Diabetes Mellitus. In diabetes mellitus
(DM), the incidence of corneal abnormalities is as high as
that of retinal abnormalities. The density of nerve fibers in
the diabetic patients has been reported to have a negative
correlation with the duration of the diseases [135]. It is
previously reported that DM patient has a decreased corneal
sensitivity [136, 137] and a decrease in the nerve fiber bundles
detected by IVCMwhich precedes corneal sensitivity impair-
ment [137]. Reduction in neurotrophic stimuli induces a thin
epithelial layer that may lead to recurrent corneal erosion
[137]. Mocan et al. reported that patients with proliferative
diabetic retinopathy had significantly lower subbasal nerve
densities than patients with diabetes without retinopathy
[138]. The latest report indicates that subbasal nerve changes
precede other clinical and electrophysiological signs of neu-
ropathy and corneal sensitivity testing as surrogatemarkers in
the assessment of diabetic peripheral and cardiac autonomic
neuropathy [139].
4.4. Diabetic Keratopathy. Diabetic keratopathy may be the
most clinically problematic NK in ophthalmology. Neu-
rotrophic corneal ulcers caused by DM have been known for
long time [140]. It is thought that diabetic keratopathy is a
representative of the corneal neuropathy due to diabetes [141].
DM patients have an increased risk of developing epithe-
lial fragility, corneal recurrent epithelial erosion, abnormal
wound healing, and infectious keratitis. The incidence of
these corneal disorders has been estimated to be in 47–64%
among DM patients [142].
4.5. Other Clinical Cases
4.5.1. Refractive Surgery. During Laser in Situ Keratomileusis
(LASIK) surgery, it is necessary to cut the corneal stroma to
fashion the flap. Mechanical damage to the nerves results in
LASIK-induced neurotrophic epitheliopathy (LINE), which
has a serious role in dry eye following the surgery [143].
Severe destruction of subbasal corneal nerves due to flap
formation is thought to cause post-LASIK dry eye [144].
In recent years, however, femtosecond laser assisted LASIK
has been reported to have a lower incidence of LINE and
decreased severity than the conventional microkeratome
assisted LASIK [145]. In contrast to the fact that the subbasal
nerve plexus appears to be fully regenerated at 5 to 8 months
following photorefractive keratectomy (PRK) [146, 147], it
remains incomplete for up to 5 years following LASIK [148].
Additionally, small incision lenticule extraction (SMILE)
procedure using femtosecond laser to create an intrastromal
lenticule is done for refractive surgery [144]. Since SMILE
only makes small corneal incision (tunnel), there may be
nonserious injury on corneal nerves. Then the SMILE is
considered to prevent iatrogenic dry eye [144].
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4.5.2. Keratoplasty. With regard to penetrating keratoplasty
(PKP), in which it is necessary to transect all corneal nerves,
several articles [149, 150] report that the subbasal nerves are
still tortuous and disorganize 40 years after surgery. High
subbasal nerve densities in the corneal graft after PKP for
keratoconus have also been reported [150]. The discrepancy
between the previous observations may be due to differences
in the causative disease, which affect the morphology and/or
pathophysiology of the corneal nerve fibers.
4.5.3. Postherpetic Neurotrophic Ulcer. Although the current
treatment with antiviral medication reduces viral replication
and also shortens both the disease course and the duration of
symptoms, it helps maintain the herpes virus in latency [151].
Corneal sensitivity tomechanical stimulation decreases as the
number of episodes of herpetic keratitis recurrence. NK with
loss of corneal lustre and an irregularity of the corneal surface
can develop in patients with recurrent herpetic epithelial
keratitis because of impairment of corneal sensation [152,
153].
4.5.4. Dry Eye. In Sjo¨gren syndrome, most studies coincide
with the fact that there is increased tortuosity of the sub-
basal nerves [154–156]. In non-Sjo¨gren dry eye patients an
increased tortuosity is also closely related to the severe dry
eye [157].
4.6. Managements of NK. The therapeutic strategy to treat
NK must consider the interactions between nerve regener-
ation and inflammatory pathways. Eye drops with preserva-
tives should not be used. Benzalkonium chloride, widely used
in many ophthalmic solutions, increases corneal inflamma-
tion and has a direct neurotoxic effect. Use of preservative free
topical lubricants is essential for minimizing evaporation of
the tears. Protecting the ocular surface with a soft contact lens
bandage, tarsorrhaphy, and conjunctival flaps are effective
for NK after stage 2. Eye drops containing peptides based
on SP, a trigeminal nerve neurotransmitter, and insulin-
like growth factor-1 (IGF-1), a multifunctional regulatory
peptide that shares structural homologywith proinsulin, have
been reported to be effective in the prevention of superficial
punctate keratitis in diabetic patients [158].
5. Conclusion
The morphology and distribution pattern of human corneal
nerves examined by histochemical methods and in vivo con-
focal microscopy are very similar to those of animal model,
especially to mice. Taken together, stromal nerve fibers are
radially derived from thick limbal nerve fibers and then run
towards the central area of the cornea forming subepithelial
stromal nerve plexus. From the plexus several nerves branch
off vertically passing through Bowman’s membrane and run
underneath the basal epithelial cells generally called subbasal
leash fibers. The leash fibers make interconnections with
each other (subbasal nerve plexus). The thin leash fibers
perpendicularly give rise to intraepithelial nerve fibers and
finally reach the upper epithelial cells leaving the beads of
terminals. At the center of the cornea leash fibers show a
whirl-like appearance. In the rat cornea, stromal subepithelial
nerve fibers are nonspecific acetylcholinesterase- (NsAchE-)
positive but thick meshwork bundles of subbasal leash fibers
are never NsAchE-positive; that is, while the former are IB4-
or TRPV1-negative and capsaicin-insensitive nerve fibers, the
latter is NsAchE-negative but capsaicin-sensitive. These two
nerve fiber groups seem to be separate populations at least in
the rat cornea.
Until recently, a number of TRP channels (TRPV1-4,
TRPA1, TRPC4, and TRPM8) are found in the corneal nerve
fibers. Besides the thermal sensation, they have many func-
tions such as protection from dry eye (humidity detectors
sensing the evaporation of the corneal surface or inhibi-
tion from hypotonic challenge of the epithelium; TRPV4,
TRPM8) and injury (TRPV1, TRPA1), wound healing
(epithelial cell proliferation; TRPV1, TRPV3, and TRPC4),
and contribution of pain and inflammation (TRPV1). The
use of agonists or antagonists of these TRP channels are
innovative strategy for the patients with various kinds of
corneal diseases.
The causal relationships between morphological changes
of subbasal corneal leash fibers and neurotrophic keratopathy
(NK) are presented in the patients of diabetes mellitus,
refractive surgery, keratoplasty, dry eye in Sjo¨gren or non-
Sjo¨gren syndrome, and herpetic epithelial keratitis.TheNK is
classified into three stages, that is, appearances of superficial
punctate keratitis, corneal epithelial hyperplasia, stromal
scarring, and neovascularization (1st stage), a persistent
epithelial defect (PED) (2nd stage), and a corneal ulcer with
inflammatory sign and severe pain (3rd stage). Treatment
with preservative free topical lubricants is crucial for man-
agement of NK. Eye drops of neurotransmitters, substance P
or growth factors, are effective for prevention of superficial
punctate keratopathy after surgery in diabetic patients.
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